Esperion Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $106k | 35k | 2.99 |
| 2023-09-30 | $35k | 35k | 0.99 |
| 2023-06-30 | $22k | 16k | 1.41 |
| 2023-03-31 | $48k | 30k | 1.61 |
| 2022-12-31 | $178k | 29k | 6.21 |
| 2022-03-31 | $79k | 17k | 4.62 |
| 2021-09-30 | $271k | 23k | 12.03 |
| 2021-06-30 | $371k | 18k | 21.17 |
| 2021-03-31 | $478k | 17k | 28.05 |
| 2020-12-31 | $262k | 10k | 26.03 |
| 2020-09-30 | $489k | 13k | 37.14 |
| 2020-06-30 | $9.5M | 185k | 51.31 |
| 2020-03-31 | $6.3M | 201k | 31.53 |
| 2019-12-31 | $2.6M | 43k | 59.64 |
| 2019-09-30 | $13M | 341k | 36.66 |
| 2019-06-30 | $16M | 336k | 46.52 |
| 2019-03-31 | $19M | 466k | 40.15 |
| 2018-12-31 | $14M | 297k | 46.00 |
| 2018-09-30 | $13M | 303k | 44.37 |
| 2018-06-30 | $12M | 303k | 39.19 |
| 2018-03-31 | $21M | 295k | 72.33 |
| 2017-12-31 | $13M | 190k | 65.84 |
| 2017-06-30 | $3.8M | 82k | 46.28 |
| 2017-03-31 | $3.3M | 94k | 35.31 |
| 2016-12-31 | $1.2M | 98k | 12.52 |
| 2016-09-30 | $1.4M | 100k | 13.85 |
| 2016-06-30 | $949k | 96k | 9.88 |
| 2016-03-31 | $1.6M | 97k | 16.91 |
| 2015-12-31 | $2.1M | 97k | 22.26 |
| 2015-09-30 | $2.1M | 89k | 23.59 |
| 2015-03-31 | $12M | 125k | 92.60 |